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Abstract
Mutations in mitochondrial DNA (mtDNA) can cause mitochondrial disease, a group of met-
abolic disorders that affect both children and adults. Interestingly, individual mtDNA muta-
tions can cause very different clinical symptoms, however the factors that determine these
phenotypes remain obscure. Defects in mitochondrial oxidative phosphorylation can disrupt
cell signaling pathways, which may shape these disease phenotypes. In particular, mito-
chondria participate closely in cellular calcium signaling, with profound impact on cell func-
tion. Here, we examined the effects of a homoplasmic m.13565C>T mutation inMT-ND5 on
cellular calcium handling using transmitochondrial cybrids (ND5 mutant cybrids). We found
that the oxidation of NADH and mitochondrial membrane potential (Δψm) were significantly
reduced in ND5 mutant cybrids. These metabolic defects were associated with a significant
decrease in calcium uptake by ND5 mutant mitochondria in response to a calcium transient.
Inhibition of glycolysis with 2-deoxy-D-glucose did not affect cytosolic calcium levels in con-
trol cybrids, but caused an increase in cytosolic calcium in ND5 mutant cybrids. This sug-
gests that glycolytically-generated ATP is required not only to maintain Δψm in ND5 mutant
mitochondria but is also critical for regulating cellular calcium homeostasis. We conclude
that the m.13565C>T mutation inMT-ND5 causes defects in both mitochondrial oxidative
metabolism and mitochondrial calcium sequestration. This disruption of mitochondrial cal-
cium handling, which leads to defects in cellular calcium homeostasis, may be an important
contributor to mitochondrial disease pathogenesis.
Introduction
Mitochondria provide the main source of energy in eukaryotic cells, oxidizing sugars, fats and
amino acids to generate ATP by oxidative phosphorylation (OXPHOS). This series of enzy-
matic reactions is performed by five protein complexes (I-V) within the mitochondrial inner
membrane. Complex I (NADH: ubiquinone oxidoreductase) and II (succinate-ubiquinone oxi-
doreductase) accept electrons from the TCA cycle, which are then passed to molecular oxygen
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via complexes III (ubiquinol: cytochrome c oxidoreductase) and IV (ferrocytochrome c: oxygen
oxidoreductase). This transfer of electrons induces the pumping of protons out of the mito-
chondrial matrix by complexes I, III and IV to generate a mitochondrial membrane potential
(Δψm), which is subsequently used by complex V (FoF1-ATP synthetase) to generate ATP [1].
Mitochondria are unique organelles in that they contain their own circular genome. Mito-
chondrial DNA (mtDNA) encodes 13 polypeptides, all of which are protein subunits of the
OXPHOS complexes I, III, IV and V. The mitochondrial genome also encodes the 12S and 16S
rRNAs, as well as the 22 tRNAs that are specific for mitochondrial protein synthesis.
Mutations in mtDNA can disrupt OXPHOS function and cause mitochondrial disease, a
diverse group of multi-systemic disorders that commonly affect the brain, heart and skeletal mus-
cle. This includes syndromes such as mitochondrial encephalomyopathy, lactic acidosis and
stroke-like episodes (MELAS), a heterogeneous disorder that presents with myopathy, encepha-
lopathy and features of central nervous system involvement [2]. Conversely, somemtDNAmuta-
tions result in isolated symptoms, such as Leber Hereditary Optic Neuropathy (LHON), a form
of acute blindness due to the specific loss of retinal ganglion cells in the optic nerve [3].
Apart from their essential role in generating ATP, mitochondria also perform many other
important functions. In particular, mitochondria act as local calcium (Ca2+) buffers to tightly
regulate intracellular Ca2+ concentration [4]. Mitochondrial utilize their Δψm to sequester
Ca2+, allowing them to shape spatiotemporal cytosolic Ca2+ signaling within the cell [5]. The
influx of Ca2+ into the mitochondria subsequently promotes the activity of three rate-limiting
dehydrogenases of the citric acid cycle, which in turn upregulates OXPHOS [6]. In this way,
mitochondrial calcium handling and OXPHOS function are tightly interlinked.
Apart from disrupting mitochondrial ATP production, mtDNA mutations have also been
shown to cause mitochondrial Ca2+ handling defects. In fibroblasts from patients with MELAS,
levels of ionized Ca2+ at rest are elevated compared to controls, with both Δψm and mitochon-
drial Ca2+ sequestration diminished [7]. Similarly, calcium homeostasis is altered in cybrids
generated from the fibroblasts of patients with myoclonic epilepsy with ragged-red fibers
(MERRF) [8].
We have previously shown that transmitochondrial cybrid cells carrying a homoplasmic
m.13565C>T mtDNAmutation, which results in a p.Ser410Phe amino acid change in the
complex I subunit ND5, have defects in mitochondrial respiration and a reduced Δψm [9].
Here, we examined the effects of this mutation on cell Ca2+ homeostasis and mitochondrial cal-
cium handling, and found that mutant cybrid mitochondria have reduced levels of stored Ca2+
and a decreased capacity to accumulate increases in cytoplasmic Ca2+. These findings aid our
understanding of the connection between OXPHOS dysfunction and mitochondrial Ca2+
homeostasis and how both can contribute to mitochondrial disease pathogenesis.
Materials and Methods
Cell lines and chemicals
All chemicals were from Sigma (St, Louis, MO, USA) unless otherwise specified. All cells were
grown in RPMI 1640 Medium (ThermoFisher Scientific, Waltham, MA, USA) supplemented
with 10% fetal bovine serum (ThermoFisher), 4.5 mg/mL glucose, 50 μg/mL uridine, and 1
mM pyruvate at 37°C and 5% CO2 unless otherwise specified.
Human mitochondrial cybrids used in this study were generated as previously described
using mtDNA-less 143B osteosarcoma cells (ρ0) as the nuclear donors [9]. Cybrids contained
either control wild-type mtDNA (CON) or a homoplasmic m.13565C>T mutation in theMT-
ND5 gene (ND5) which was captured from fibroblasts from a patient with mitochondrial ence-
phalomyopathy and lactic acidosis with stroke-like episodes (MELAS) [9].
Mitochondrial DNAMutations and Calcium Handling Defects
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Fluorescent Imaging of Cell Calcium
For measurements in the presence of calcium, cells were incubated in buffer containing 156
mMNaCl, 3 mM KCl, 2 mMMgSO4, 1.25 mM KH2PO4, 10 mM D-glucose, 2 mM CaCl2, 10
mMHEPES pH 7.35 (Record Solution, RS), 5 μg/mL fura-2 AM (ThermoFisher) and 0.005%
pluronic (ThermoFisher) for 30 min in RS. Cells were then washed with 1xPBS before imaging
in RS, with 10 μM ionomycin or 5 mM 2-deoxy-D-glucose (2DG) added as indicated.
For measurements in the absence of calcium, cells were incubated in buffer containing 156
mMNaCl, 3 mM KCl, 2 mMMgSO4, 1.25 mM KH2PO4, 10 mM D-glucose, 10 mMHEPES
pH 7.35, 0.1 mM EGTA (Ca2+ free RS), 5 μg/mL fura-2 AM and 0.005% pluronic for 30 min.
Cells were then washed with 1xPBS before imaging in Ca2+ free RS, with additions of 1 μM
thapsigargin and 10 μM ionomycin added as indicated.
Fluorescent images were captured on a Nikon epifluorescence inverted microscope with a
40X objective. A xenon arc lamp with 10 nm band-pass filters centered at 340 and 380 nm was
used for excitation (Cairn Research, Kent, UK), with emitted light passing through a 515 nm
long-pass filter to an interline transfer cooled CCD camera (Orca ER, Hamamatsu). Images
were digitized to 12-bit and analyzed using Kinetic Imaging software (Liverpool, UK).
Fluorescent Imaging of Mitochondrial Calcium and Mitochondrial
Membrane Potential
Mitochondrial membrane potential (Δψm) was measured by incubating cells in RS with 20 nM
tetramethylrhodamine, methyl ester, perchlorate (TMRM) (ThermoFisher) and 10 μM verapa-
mil (which is required to inhibit TMRM export from the cell on the multidrug transporter).
Cells were allowed to equilibrate the dye for at least 45 min at room temperature before imag-
ing. Additions of 2 mM cyanide (CN-) or 10 μM carbonyl cyanide p-trifluoromethoxyphenyl-
hydrazone (FCCP) were made as indicated.
For simultaneous measurement of Δψm and mitochondrial calcium [Ca
2+]m, cells were
incubated with 5 μg/mL fluo-4 AM (ThermoFisher), 0.005% pluronic, 20 nM TMRM and
10 μM verapamil for 45 min in RS. Cells were washed in Ca2+ free Hank’s buffered salt solution
(HBSS, with 500 μM EGTA), permeabilized with 25 μg/mL digitonin in 6 mMNaCl, 130 mM
KCl, 7.8 mMMgCl2, 1 mM KH2PO4, 0.4 mM CaCl2, 2 mM EGTA, 10 mMHEDTA, 2 mM
malate, 2 mM glutamate, 2 mM ADP, 20 mMHEPES pH 7.35 (intracellular medium, IM),
then left to equilibrate in 200 nM TMRM and 1 μM thapsigargin in IM. Aliquots of 0.4 mM
CaCl2 were added to the cells at 3.5 min intervals. Final free Ca
2+ ion concentration [Ca2+] was
calculated using Chelator software [10].
Δψm and fluo-4 calcium measurements were made by acquiring images with a Carl Zeiss
510 inverted laser scanning confocal microscope (Oberkochen, Germany). TMRM and fluo-4
were excited using 543 nmHe-Ne and 488 nm argon laser lines, respectively. NADH autofluor-
escence was measured using the 362 nm UV laser line. Images were analyzed using Carl Zeiss
or Kinetic Imaging software, with mitochondrial calcium measured by selecting regions of
interest that specifically co-localized with mitochondrial TMRM signals.
Statistical analyses for all experiments were performed using imaging data from three sepa-
rate experiments, with significant differences determined using Student's two-tailed t-tests.
Results
NADH oxidation by Complex I is reduced in ND5 mutant cybrids
We first examined the impact of the m.13565C>T mutation on mitochondrial function. Mea-
surements of NADH ‘auto’ fluorescence reflects the redox balance of the NAD+/NADH pool,
Mitochondrial DNAMutations and Calcium Handling Defects
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as only NADH is fluorescent. We explored the relationship between mitochondrial NADH redox
state and Δψm by inhibiting cytochrome c oxidase (Complex IV) with cyanide (CN
-), which
blocks electron flow through the respiratory chain. In the control cybrid (CON), CN- treatment
caused the inhibition of NADH oxidation by Complex I, as observed by an increase in NADH
autofluorescence (Fig 1A). However, blocking electron flow with CN- did not collapse Δψm, as
the FoF1-ATP synthetase switches to function in reverse, maintaining Δψm [11] (Fig 1B).
Blockade of Complex IV with CN- in the ND5 mutant cybrid did not alter NADH oxida-
tion, suggesting that at rest the rate of NADH oxidation by complex I is very low (Fig 1A). Δψm
in ND5 mutant cybrids, which is lower than in control cybrids, was also unchanged upon the
addition of CN-, as it is maintained by reverse function of the FoF1-ATPase as previously
shown [9] (Fig 1B).
As ρ0 cells do not have functional OXPHOS complexes to generate a Δψm, they maintain a
potential through the reversal of both the ANT and an incomplete FoF1-ATPase [9, 12]. Thus,
the addition of CN- had no effect either on NADH oxidation or Δψm in ρ
0 cells (Fig 1A and 1B).
The protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) will always
collapse any potential based on proton distribution. In the control cybrid (CON), FCCP caused a
Fig 1. NADH oxidation and Δψm are reduced in ND5mutant cybrids.NADH oxidation (NADH
autofluorescence) and Δψm (TMRM fluorescence) were measured concurrently by confocal microscopy. (A)
In control (CON) cybrids, inhibition of respiration with cyanide (CN-) increased NADH autofluorescence,
reflecting a decrease in NADH oxidation. Conversely, CN- had no effect on NADH oxidation in ND5 mutant
cybrids or ρ0 cells. Stimulation of respiration with the uncoupler FCCP significantly increased NADH oxidation
in CON cybrids, induced a small increase in NADH oxidation in ND5 mutant cybrids, but did not change
NADH oxidation in ρ0 cells. (B) CN- did not cause any significant change in Δψm in CON cybrids, ND5mutant
cybrids or ρ0 cells, whereas FCCP collapsed Δψm in all cell types. Data is mean ± s.d. n = 3.
doi:10.1371/journal.pone.0154371.g001
Mitochondrial DNAMutations and Calcium Handling Defects
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collapse of Δψm and the rapid oxidation of NADH (indicated by a decrease in NADH autofluores-
cence) as respiration is stimulated (Fig 1B). NADH oxidation increased modestly in ND5 mutant
cybrids after depolarization with FCCP, suggesting that there is a small reserve respiratory capacity
when stimulated (Fig 1A). This result concurs with our previous findings, where the ratio of
uncoupled/coupled respiration (as an indicatory of reserve respiratory capacity) was only 1.25 in
ND5mutant cybrid cells (compared to a ratio of 2.0 in control cybrid cells (p<0.05)) [9].
FCCP did not stimulate NADH oxidation in ρ0 cells (Fig 1A), despite collapsing the small
Δψm (Fig 1B), confirming the absence of functional OXPHOS in these cells.
Levels of stored calcium are reduced in ND5 mutant cybrids
We used the ratiometric dye fura-2 to perform a quantitative comparison of cytosolic free Ca2+
[Ca2+]c in control (CON) and ND5 mutant cybrids in real time. At rest in physiological saline
(RS, with 2 mM Ca2+), the [Ca2+]c in control (CON) and ND5 mutant cybrids was the same,
whereas resting [Ca2+]c was significantly higher in ρ
0 cells (p<0.05) (Fig 2A). This is most
likely a result of impaired Ca2+ clearance mechanisms due to the ATP depletion observed in
this cell type [12, 13]. The Ca2+ ionophore ionomycin, at a concentration of 10 μM, releases
Ca2+ preferentially from the endoplasmic reticulum (ER) and the mitochondria into the cyto-
sol. Ionomycin treatment revealed significantly less stored Ca2+ in ND5 mutant cybrids
(45.3 ± 11.0% of control (CON) cybrids, p<0.05) (Fig 2A). Stored Ca2+ in ρ0 cells was also sig-
nificantly less than in control cybrids (22.4 ± 6.2%, p<0.05) (Fig 2A).
We also examined the release of stored Ca2+ in the absence of extracellular Ca2+ (Ca2+ free
RS) (Fig 2B). Under these conditions, there was no significant difference in the levels of resting
[Ca2+]c in control (CON) cybrids, ND5 mutant cybrids or ρ
0 cells (Fig 2B). However, the addi-
tion of ionomycin resulted in a similar pattern of Ca2+ release, in that the increase in [Ca2+]c
was significantly reduced in ND5 cybrids (36.6 ± 4.6%, p<0.05) and ρ0 cells (17.9 ± 3.7%,
p<0.05) compared to the controls (Fig 2B). The total increase in [Ca2+]c induced by ionomycin
was reduced in each cell type compared to our findings presented in Fig 2A, as would be
expected in the absence of free extracellular Ca2+ (Fig 2B).
We next used thapsigargin to measure the release of Ca2+ specifically from the ER, followed
by ionomycin, which will then release calcium sequestered in the mitochondria. Thapsigargin
inhibits the Ca2+-ATPase, causing depletion of ER Ca2+ and an increase in [Ca2+]c. Subsequent
addition of ionomycin, in the absence of extracellular free Ca2+, will then release Ca2+ from any
remaining intracellular pool, which will be dominated by the mitochondria.
Cells were incubated in Ca2+ free buffer, followed by the addition of thapsigargin. This
resulted in the release of Ca2+ from ER stores in both control (CON) cybrids and ND5 mutant
cybrids (Fig 3). Although this Ca2+ release was both reduced and delayed in ND5 mutant
cybrids, neither was statistically significant. In comparison, ρ0 cells showed no significant
release of ER Ca2+, suggesting that the ATP depletion observed in these cells disrupts ER Ca2+
uptake [12, 13] (Fig 3).
Subsequent addition of ionomycin released Ca2+ from the mitochondria in both control
(CON) and ND5 mutant cybrids, however, stored Ca2+ in ND5 mutant mitochondria was sig-
nificantly lower (66.4 ± 15.8%, p<0.05) (Fig 3). Releasable Ca2+ in ρ0 cell mitochondria was
also significantly lower than the control cybrid (21.3 ± 11.7%, p<0.05) (Fig 3).
Mitochondrial calcium buffering power is significantly reduced in ND5
mutant cybrids
In order to measure the ability of the mitochondria to buffer increases in Ca2+, cybrids were
loaded with fluo-4 and then permeabilized with digitonin in a cytosol-like buffer (intracellular
Mitochondrial DNAMutations and Calcium Handling Defects
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medium, IM) containing 62 nM free Ca2+. In addition, thapsigargin was added to deplete ER
Ca2+ stores. Under these conditions, fluo-4 is lost from both the cytosol and ER, with the only
dye remaining trapped in the mitochondria (Fig 4C). Aliquots of Ca2+ were then added directly
to the cells and mitochondrial calcium [Ca2+]m and Δψm (using TMRM) were measured simul-
taneously by confocal microscopy.
Increasing [Ca2+] to 327 nM caused no change in [Ca2+]m in control cybrids (Fig 4A),
although slight depolarization and recovery of Δψm is evident (Fig 4B). Further increases to
Fig 2. ND5mutant cybrids exhibit reduced levels of stored calcium. Free cytoplasmic calcium [Ca2+]c
was measured using the ratiometric dye fura-2 AM on an epifluorescence imaging system. Increases in
[Ca2+]c were significantly lower in ND5 mutant cybrids and ρ
0 cells than in control (CON) cybrids after the
addition of the calcium ionophore ionomycin in either calcium-containing (A) or a calcium-free buffer (B). Data
is mean ± s.d. n = 3. *p<0.05.
doi:10.1371/journal.pone.0154371.g002
Mitochondrial DNAMutations and Calcium Handling Defects
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[Ca2+] in control cybrids increased [Ca2+]m progressively, producing a large depolarization of
Δψm at 2.48 μM [Ca
2+]c (Fig 4B). At higher [Ca
2+], an intact Δψm was still evident, as the addi-
tion of 10 μM FCCP still induced the collapse of Δψm (Fig 4B).
In contrast, mitochondrial calcium accumulation was reduced significantly in ND5 mutant
cybrids, and no increase in [Ca2+]m was measurable until [Ca
2+] reached 1.28 μM (Fig 4A). At
a [Ca2+] of 2.48 μM, the increase in [Ca2+]m was only 47.5% of that seen in control cybrid mito-
chondria (Fig 4A). This reduced Ca2+ uptake by ND5 mutant mitochondria was also observed
at the highest [Ca2+] tested, 11.3 μM, with [Ca2+]m only 59.1% of control cybrid mitochondria
(Fig 4A).
We have previously observed that Δψm in resting, intact ND5 mutant cybrids was signifi-
cantly lower than in matching control cybrids (72%, p<0.05) [9]. In permeabilized cells, the
TMRM intensity in ND5 mutant mitochondria was only 31.3% (p<0.05) of control cybrid
mitochondria at a [Ca2+] of 62 nM (Fig 3B). This further decrease in ND5 mutant Δψm is likely
a result of the diminished ATP pool after permeabilization, as glycolytically derived ATP is
required (in part) to maintain Δψm in ND5 mutant mitochondria [9].
ρ0 mitochondria exhibited a very limited capacity for Ca2+ accumulation, with [Ca2+]m only
24% of control values when [Ca2+] was elevated to 2.48μM (Fig 4A). Δψm did not change at all
in ρ0 cells with increases in [Ca2+] (Fig 4B), however the addition of FCCP still elicited a small
depolarization (Fig 4B). Of note, Δψm in ND5 mutant mitochondria was higher than in ρ
0
mitochondria after permeabilization, suggesting that the reduced respiratory activity in ND5
mutant mitochondria can maintain a modest Δψm in the absence of glycolytically derived ATP
(Fig 4B).
Examples of images from which the simultaneous measurements of [Ca2+]m (with fluo-4;
green) and Δψm (with TMRM; red) were made at various [Ca
2+] in control (CON) cybrids,
ND5 mutant cybrids and ρ0 cells are shown (Fig 4C).
Fig 3. ND5mutant mitochondria have reduced levels of stored calcium. Free cytoplasmic calcium [Ca2+]c was measured using the ratiometric dye fura-2
AM on an epifluorescence imaging system. Thapsigargin was used to block the Ca2+-ATPase to release endoplasmic reticulum (ER) calcium stores,
followed by the addition of ionomycin to release mitochondrial calcium. Calcium release from ER stores was not different between control (CON) cybrids and
ND5 mutant cybrids, but was significantly reduced in ρ0 cells. However, calcium release frommitochondrial stores was significantly lower in ND5 mutant
cybrids lower (66.4 ± 15.8%) that CON cybrids. Stored mitochondrial calcium was also significantly lower in ρ0 cells compared to CON cybrids
(21.3 ± 11.7%). Data is mean ± s.d. n = 3.*p<0.05.
doi:10.1371/journal.pone.0154371.g003
Mitochondrial DNAMutations and Calcium Handling Defects
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Fig 4. ND5mutant mitochondria have a reduced ability to buffer calcium.Mitochondrial calcium [Ca2+]m
(A) and Δψm (B) were measured concurrently by confocal microscopy using fluo-4 and TMRM in digitonin
permeabilized cells. Exogenous calcium was added in sequential aliquots at the concentrations and times
indicated (*). Control (CON) cybrid mitochondria were able to buffer more calcium than both ND5 mutant
cybrid mitochondria and ρ0 cell mitochondria. Increases in [Ca2+] up to 2.48 μMwere buffered by CON cybrid
Mitochondrial DNAMutations and Calcium Handling Defects
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Calcium buffering in ND5 mutant cybrids is dependent on ATP derived
from glycolysis
We have previously shown that ND5 mutant cybrids primarily use glycolysis to generate ATP,
and that this ATP is utilized to partially maintain Δψm [9]. Here, we examined the effects of
inhibiting glycolysis using 5mM 2-deoxy-D-glucose (2DG) on [Ca2+]c.
In control (CON) cybrids, [Ca2+]c remained unchanged up to 35 min after 2DG administra-
tion (Fig 5). However, in ND5 mutant cybrids, [Ca2+]c began to increase after approximately
10 min of 2DG treatment and remained significantly higher in ND5 than in control (CON)
cybrids up to 35 min of treatment (Fig 5, p<0.05). In contrast, [Ca2+]c increased significantly
in ρ0 cells after only 5 min 2DG treatment (p<0.05), followed by a slight reduction for the
remainder of the experiment (Fig 5).
Discussion
The relationship between mitochondrial metabolism and calcium signaling was first recog-
nized in the early 1960’s, when it was discovered that isolated mitochondria could take up cal-
cium [14]. Since that time, it has become apparent that mitochondrial calcium handling is
important in a range of different cellular functions, including neuronal signaling and induction
of cell death [15]. Furthermore, it is now clear that defects in mitochondrial metabolism can
disrupt cellular calcium homeostasis and contribute to human disease pathology. Various path-
ogenic mtDNA point mutations associated with mitochondrial disease have been shown to
affect mitochondrial calcium handling. In fibroblasts from patients with MELAS, Δψm was
found to be reduced, with an associated increase in basal cytosolic Ca2+ [7]. Similarly, cybrid
mitochondria, with a step-wise decrease (followed by recovery) of Δψm evident. Δψm was lower in both ND5
mutant cybrids and ρ0 cells, and was not affected by increases in [Ca2+]. (C) Confocal images of CON
cybrids, ND5 mutant cybrids and ρ0 cells showing the simultaneous staining of [Ca2+]m (fluo-4, green) and
Δψm (TMRM, red). The number of the calcium aliquot and the [Ca
2+] are indicated. Data is mean ± s.d. n = 3.
White scale bars = 10 μm.
doi:10.1371/journal.pone.0154371.g004
Fig 5. Calcium buffering in ND5mutant cybrids is dependent on glycolytically-derived ATP. Free
cytoplasmic calcium [Ca2+]c was measured using the ratiometric dye fura-2 AM on an epifluorescence
imaging system. Inhibition of glycolysis with 2-deoxy-D-glucose (2DG) did not affect [Ca2+]c in control (CON)
cybrids. Conversely, a significant increase in [Ca2+]c was observed in ρ
0 cells after approximately 5 min
2-deoxy-D-glucose treatment. [Ca2+]c also increased significantly in ND5 mutant cybrids after approximately
12 min treatment, however this increase in [Ca2+]c was smaller than in ρ
0 cells. Data is mean ± s.d. n = 3.
doi:10.1371/journal.pone.0154371.g005
Mitochondrial DNAMutations and Calcium Handling Defects
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cells carrying the m.3243A>Gmutation associated with MELAS were also found to exhibit
increased cytosolic calcium levels [16]. Mitochondrial calcium homeostasis is also altered in
cybrids carrying the m.8344A>G tRNALys mutation associated with myoclonic epilepsy with
ragged-red fibers (MERRF) and have been shown to have a decreased capacity to take up cyto-
solic calcium [8, 17].
In ND5 mutant cybrid mitochondria, we observed a decrease in both the mitochondrial cal-
cium content and their ability take up increases in exogenous calcium. The homoplasmic
m.13565C>TmtDNAmutation in these cybrids causes a respiratory defect that results in a
reduced Δψm, which is maintained in-part by glycolytically-derived ATP which fuels the reverse
action of the ATP synthase [9]. Blocking glycolysis reduces Δψm in ND5 mutant mitochondria
further, with a subsequent elevation of cytosolic calcium levels. These findings support the notion
that efficient mitochondrial metabolism is not only important for generating ATP, but that it is
also critical for regulating cellular calcium homeostasis. Indeed, the calcium handling defect in
ND5 mutant cybrid mitochondria appears to be directly related to their reduced Δψm and their
reliance on glycolytically derived ATP. However, their inability to accumulate calciummay also
be due to defective calcium influx mechanisms. The inherent respiratory defect in these cells will
result in a diminished electrogenic force across the mitochondrial inner membrane, which in
turn may reduce calcium influx via the mitochondrial calcium uniporter [18].
When [Ca2+] reached 2.48 μM in control cybrids, a large depolarization of Δψm was
observed, indicating the initiation of mitochondrial membrane permeability transition. Inter-
estingly, a large membrane depolarization was not observed in either the ND5 mutant cybrids
or ρ0 cells. This may be due to the fact that resting Δψm in both these cell types is lower than
Δψm in control cybrids following membrane permeability transition. Nevertheless, it is possible
that mitochondrial permeability transition, or low conductance pore opening, is occurring in
both ND5 mutant cybrids and ρ0 cells at high [Ca2+].
Calcium is particularly important in neuronal cells, where calcium signaling is critical for
signal processing. In these cells, defects in mitochondrial metabolism will have severe func-
tional consequences, as the reduction in ATP generation will lead to elevated cytoplasmic cal-
cium levels that disturb cell signaling pathways, confound normal signal processing, and may
even promote cell death via calcium overload and/or excitotoxicity [19]. In neurons differenti-
ated from mouse embryonic stem cells, which carry mtDNAmutations that disrupt OXPHOS
complex I or IV activity, stimulation with glutamate resulted in calcium transients that were no
different to control cybrid neurons [20]. However, repeated stimulation in the mutant neurons
resulted in calcium transients that decayed increasingly slowly, resulting in elevated cyto-
plasmic calcium levels [20]. This loss of calcium regulation has the potential to disrupt neuro-
nal transmitter release, long-term potentiation and depression, as well as developmental
remodeling [20].
It has long been postulated that disruption of cell death signaling pathways may be a con-
tributing factor to mtDNA disease pathogenesis [21]. Furthermore, calcium homeostasis may
play an important role in this process. Cybrid cells carrying the m.8344A>GmtDNAmutation
associated with MERFF were shown to be hypersensitive to staurosporine-induced cell death,
and that this hypersensitivity was mediated by the calcium-dependent activation of calpains
[22]. Cybrids carrying the m.8993T>G NARP mutation also display increased sensitivity to
cell death induction, in this case by thapsigargin [17]. However, MERRF cybrids are protected
from thapsigargin-induced cell death, even though both the NARP and MERFF mutant cybrids
display similar defects in mitochondrial calcium uptake [17]. This suggests that other factors
are involved in regulating the response of these two mutant cybrids to ER stress. Indeed, NARP
mutant cybrids showed a significant increase in free radical generation [17] and also disturbed
actin cytoskeleton organization, which subsequently disrupts capacitative calcium entry [23].
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The ND5 mutant cybrids showed a reduced ability to generate ATP and exhibit defects in
mitochondrial calcium accumulation, two features which serve to compound mitochondrial
disease pathology. Of note, the m.13565C>TMT-ND5mutation studied here was originally
isolated from a MELAS patient who also carries a mutation in POLG, which encodes the cata-
lytic subunit of the mitochondrial DNA polymerase [24]. Nevertheless, our transmitochondrial
cybrid studies clearly show that theMT-ND5mutation disrupts both mitochondrial respiratory
function and calcium handling, and suggests that theMT-ND5mutation may play a role in
modulating the disease phenotype in conjunction with the POLGmutation.
Changes in cytosolic calcium concentration signal the mitochondria to match energy supply
with demand, in particular by regulating mitochondrial dehydrogenase activity [25–28]. How-
ever, failure of mitochondria to accumulate calcium, as in ND5 mutant cybrids, will result in
the loss of TCA cycle enzyme stimulation, a lower than required respiratory rate and subse-
quently a reduced Δψm. This will have a profound impact on cell metabolism, with energetic
failure or collapse of Δψm leading to cell death [6]. As such, mitochondrial calcium handling is
an important factor to consider when investigating mitochondrial disease pathogenesis. Fur-
thermore, the future design of therapies for treating mitochondrial disease will need to address
not only the energetic deficits caused by OXPHOS dysfunction but also the means to re-estab-
lish mitochondrial calcium homeostasis.
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